Miro Biotech announced worldwide availability of its HPLC‑verified research‑grade peptide catalog covering India, North America, Europe, Asia‑Pacific, Africa and Latin America.
The catalog, featuring peptides such as Retatrutide, BPC‑157, GHK‑Cu, CJC‑1295, Ipamorelin and Tesamorelin, meets a minimum 99% purity verified by third‑party labs.
Indian researchers benefit from INR pricing, UPI‑enabled procurement and 7‑14 business‑day delivery across major cities, reducing cross‑border friction.
Ria Tan, VP of Global Operations, said the launch is the first stage of a catalog expansion planned throughout 2026.